Region Syddanmark
- Address
- J.B. Winsloews Vej 18, 5000 Vejle, Denmark
Cardiovascular Diseases and Heart Failure
At Region Syddanmark, the Department of Cardiology is running clinical research focused on improving care for people with chronic heart failure and related cardiovascular conditions. The studies are designed to test whether existing or added treatments can better reduce hospitalizations, serious complications, and death while supporting longer-term heart health.
- Evaluating treatment strategies for heart failure with reduced heart function
- Studying ways to lower cardiovascular events and urgent care needs
- Assessing whether additional therapies can improve outcomes in patients already receiving standard care
This work reflects a strong interest in practical therapies that may improve everyday outcomes for patients living with complex cardiovascular disease.
Nephrology, Immune System Diseases, and Pathological Conditions
The site is also active in research on kidney-related and immune-mediated disorders, including idiopathic membranous nephropathy and acute interstitial nephritis. These trials aim to understand whether targeted treatment can reduce inflammation, improve protein loss in urine, and support better recovery in patients with challenging renal disease.
- Testing therapies for idiopathic membranous nephropathy with severe proteinuria
- Investigating treatment for acute interstitial nephritis
- Exploring immune-related mechanisms that may influence kidney outcomes
This area combines diagnosis and treatment research to improve how kidney disorders are identified and managed.
Digestive System Diseases and Neoplasms
Clinical trials at this hospital in Vejle include oncology studies aimed at improving outcomes for patients with rectal cancer and other head and neck or blood-related cancers. The research is focused on comparing treatment approaches, refining cancer response, and supporting better long-term disease control.
- Studying treatment options for rectal cancer
- Evaluating therapy response in head and neck squamous cell carcinoma
- Testing approaches that may improve remission in chronic myeloid leukemia
These trials aim to strengthen oncology care by identifying more effective and better targeted treatment strategies.
Female Urogenital Diseases and Diagnostic Research
Another important focus is improving the detection of cervical dysplasia and preventing progression to cervical cancer, especially in postmenopausal women. The research is centered on making diagnostic evaluation more accurate and helping clinicians identify precancerous changes earlier.
- Improving diagnosis of cervical precancerous lesions
- Studying methods to support clearer colposcopic examination results
- Aiming to reduce the burden of cervical cancer through earlier detection
This work highlights the site’s interest in better diagnostics for women’s health and cancer prevention.
Anesthesia and Analgesia and Equipment and Supplies
The clinical trial portfolio also includes studies in anesthesia that examine how to optimize tracheal intubation and improve procedural safety for adults undergoing general anesthesia. These trials are intended to support better comfort, smoother airway management, and safer perioperative care.
- Comparing approaches for video laryngoscopy-assisted intubation
- Assessing which treatments best improve intubation conditions
- Supporting safer and more effective airway management
Research in this area helps refine everyday clinical equipment use and anesthesia practice in hospital care.
Bacterial Infections and Mycoses and Digestive System-Related Care
There is also research addressing infection prevention in patients receiving hemodialysis, especially those at higher risk because of vascular access needs. The goal is to determine whether preventive antibiotics can reduce bloodstream infections and other serious complications.
- Preventing bloodstream infection in hemodialysis patients
- Reducing severe infection risk linked to vascular access
- Testing supportive care strategies to improve safety during dialysis treatment
This reflects a practical focus on lowering infection burden in vulnerable patients with chronic kidney disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 11 therapeutic areas and 15 of 22 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Region Midtjylland2active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Region Midtjylland3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Region Syddanmark
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study of Resomelagon in Patients with Idiopathic Membranous Nephropathy and Severe Proteinuria | Synact Pharma ApS | Phase II | Recruiting | Aug 2020 | — |
IMP list
lock Showing 1 of 22 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amiloride Hydrochloride | 1 | Unknown | 2020-08-24 | 2020-08-24 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
